Obsessive-Compulsive Disorder Market Size, Share, and Trends Analysis, Emerging Therapies, and Epidemiology Forecast | Key Companies – Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others

October 20 21:14 2021
Obsessive-Compulsive Disorder Market Size, Share, and Trends Analysis, Emerging Therapies, and Epidemiology Forecast | Key Companies - Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others
Delveinsight Business Research LLP
DelveInsight’s “Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Obsessive-Compulsive Disorder Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Obsessive-Compulsive Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Obsessive-Compulsive Disorder Market

Obsessive-Compulsive Disorder: An Overview

Obsessive-Compulsive Disorder (OCD) is an anxiety disorder in which people get recurring, unwanted thoughts, ideas, or sensations (obsessions) that make them feel driven to do something repetitively (compulsions). It is associated with a profoundly diminished quality of life, social isolation, and a substantial economic burden on society. The American Psychiatric Association (APA) states that females are affected at a slightly higher rate than men, and OCD affects people of all races and socio-economic backgrounds.

Obsessive-Compulsive Disorder Market Key Facts

  • According to the NIMH, OCD currently affects approximately 1 in 40 adults and 1 in 100 children in the U.S. 

  • In a new 2017 publication, the World Health Organization’s ‘Depression and other common mental disorders’ report, OCD was included in the ‘anxiety disorders’ category. OCD ranks tenth in the World Bank’s and WHO’s ten leading causes of disability and, in the case of women aged 15–44 years, OCD occupies the fifth position.

  • A study by Nakajima A. et al.,(2018), quoted that Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan. 

Get FREE sample copy @ Obsessive-Compulsive Disorder Therapeutics Market

Key Benefits of Obsessive-Compulsive Disorder Market Report

  • The report provides an in-depth analysis of Obsessive-Compulsive Disorder Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Obsessive-Compulsive Disorder Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Obsessive-Compulsive Disorder current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Obsessive-Compulsive Disorder market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Obsessive-Compulsive Disorder Market

Owing to the launch of upcoming therapies the market size of Obsessive-Compulsive Disorder is expected to increase during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Obsessive-Compulsive Disorder market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Obsessive-Compulsive Disorder market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Obsessive-Compulsive Disorder Epidemiology Forecast

The epidemiology section covers insights about the historical and current Obsessive-Compulsive Disorder patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Obsessive-Compulsive Disorder Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Obsessive-Compulsive Disorder market or expected to get launched in the market during the study period. The analysis covers Obsessive-Compulsive Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Obsessive-Compulsive Disorder Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

The dynamics of the Obsessive-Compulsive Disorder market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of the emerging therapies.

Companies in the Obsessive-Compulsive Disorder market

  • Pfizer

  • GlaxoSmithKline

  • Eli Lilly and Company

  • Biohaven Pharmaceuticals

And many others.

Obsessive-Compulsive Disorder Therapies covered in the report includes:

  • Trigriluzole


  • Paxil


And many others.

Request for Sample @ Obsessive-Compulsive Disorder Emerging Therapies and Key Companies

Table of Content

1. Key Insights

2. Executive Summary 

3. Obsessive-Compulsive Disorder Competitive Intelligence Analysis

4. Obsessive-Compulsive Disorder Market Overview at a Glance

5. Obsessive-Compulsive Disorder Disease Background and Overview

6. Obsessive-Compulsive Disorder Patient Journey

7. Obsessive-Compulsive Disorder Epidemiology and Patient Population

8. Obsessive-Compulsive Disorder Treatment Algorithm, Current Treatment, and Medical Practices

9. Obsessive-Compulsive Disorder Unmet Needs

10. Key Endpoints of Obsessive-Compulsive Disorder Treatment

11. Obsessive-Compulsive Disorder Marketed Products

12. Obsessive-Compulsive Disorder Emerging Therapies

13. Obsessive-Compulsive Disorder Seven Major Market Analysis

14. Attribute Analysis

15. Obsessive-Compulsive Disorder Market Outlook (7 major markets)

16. Obsessive-Compulsive Disorder Access and Reimbursement Overview

17. KOL Views on the Obsessive-Compulsive Disorder Market.

18. Obsessive-Compulsive Disorder Market Drivers

19. Obsessive-Compulsive Disorder Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/